| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3029362 | Thrombosis Research | 2010 | 6 Pages |
Abstract
The IMPACT-R ADP-test is relatively insensitive to the effects of clopidogrel and cannot substitute for methods such as flowcytometric VASP-analysis and optical aggregometry. Further studies are required to establish the clinical usefulness of IMPACT-R ADP-test to accurately predict the occurrence of major adverse cardiovascular events in patients with high on-clopidogrel platelet reactivity before it can be implemented in clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jochem W. van Werkum, Heleen J. Bouman, Nicoline J. Breet, Jurriën M. ten Berg, Christian M. Hackeng,